(ENZY) Enzymatica publ - Performance 9.7% in 12m
Compare ENZY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-55.60%
#104 in Group
Rel. Strength
66.69%
#2661 in Universe
Total Return 12m
9.74%
#51 in Group
Total Return 5y
-49.99%
#90 in Group
P/E -
(?) Percentile in Group
P/E Forward 66.7
84th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -7.72%
(?) Percentile in Group
12m Total Return: ENZY (9.7%) vs XLV (-0.5%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
| LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
| NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
| SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
| SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
| SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
| NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: ENZY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ENZY
| Total Return (including Dividends) | ENZY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -30.00% | -7.37% | -5.89% |
| 3 Months | 117.09% | -4.55% | -12.45% |
| 12 Months | 9.74% | -0.54% | 6.72% |
| 5 Years | -49.99% | 46.59% | 101.06% |
| Trend Score (consistency of price movement) | ENZY | XLV | S&P 500 |
| 1 Month | -91.4% | -82.6% | -74.5% |
| 3 Months | 81.1% | -37.8% | -88.2% |
| 12 Months | -24.0% | -1.6% | 66.1% |
| 5 Years | -90.2% | 90.1% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #168 | -24.4% | -25.6% |
| 3 Month | #2 | 127% | 148% |
| 12 Month | #50 | 10.3% | 2.83% |
| 5 Years | #94 | -65.9% | -75.1% |
FAQs
Does ENZY Enzymatica publ outperforms the market?
Yes,
over the last 12 months ENZY made 9.74%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months ENZY made 117.09%, while XLV made -4.55%.
Over the last 3 months ENZY made 117.09%, while XLV made -4.55%.
Performance Comparison ENZY vs Indeces and Sectors
ENZY vs. Indices ENZY is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.29% | -24.1% | 98.9% | 3.02% |
| US NASDAQ 100 | QQQ | 3.15% | -23.7% | 99.4% | 4.21% |
| US Dow Jones Industrial 30 | DIA | 3.46% | -24.2% | 98.3% | 4.43% |
| German DAX 40 | DAX | -3.07% | -20.6% | 81.8% | -8.47% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.58% | -22.5% | 96.6% | 3.85% |
| Hongkong Hang Seng | HSI | -2.0% | -20.2% | 97.4% | -6.48% |
| India NIFTY 50 | INDA | -2.08% | -34.8% | 96.4% | 6.67% |
| Brasil Bovespa | EWZ | -1.27% | -24.9% | 95.9% | 19.2% |
ENZY vs. Sectors ENZY is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.04% | -24.3% | 90.1% | -3.80% |
| Consumer Discretionary | XLY | 3.16% | -26.1% | 96.1% | 0.52% |
| Consumer Staples | XLP | -1.01% | -33.2% | 88.7% | -4.20% |
| Energy | XLE | -2.43% | -19.9% | 97.8% | 20.0% |
| Financial | XLF | 0.92% | -25.5% | 90.8% | -9.21% |
| Health Care | XLV | 1.89% | -22.6% | 100% | 10.3% |
| Industrial | XLI | 1.17% | -25.3% | 98.8% | 4.38% |
| Materials | XLB | 0.57% | -23.4% | 106% | 17.3% |
| Real Estate | XLRE | -3.05% | -27.1% | 97.5% | -7.37% |
| Technology | XLK | 3.65% | -21.1% | 106% | 11.0% |
| Utilities | XLU | -1.02% | -29.6% | 93.1% | -14.6% |
| Aerospace & Defense | XAR | 0.60% | -30.0% | 89.1% | -14.4% |
| Biotech | XBI | -1.27% | -18.1% | 113% | 18.7% |
| Homebuilder | XHB | 1.34% | -23.2% | 117% | 18.9% |
| Retail | XRT | 0.59% | -27.9% | 104% | 14.1% |